[go: up one dir, main page]

DE102004019845A1 - Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung - Google Patents

Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung Download PDF

Info

Publication number
DE102004019845A1
DE102004019845A1 DE200410019845 DE102004019845A DE102004019845A1 DE 102004019845 A1 DE102004019845 A1 DE 102004019845A1 DE 200410019845 DE200410019845 DE 200410019845 DE 102004019845 A DE102004019845 A DE 102004019845A DE 102004019845 A1 DE102004019845 A1 DE 102004019845A1
Authority
DE
Germany
Prior art keywords
components
inorganic carbonate
microcrystalline cellulose
perindopril
cholinesterase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE200410019845
Other languages
English (en)
Inventor
Iztok Klobcar
Alesa Puncuh-Kolar
Anica Grandovec
Urska Turk
Polona Solmajer-Lampic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
KRKA Tovarna Zdravil dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd
Priority to DE200410019845 priority Critical patent/DE102004019845A1/de
Priority to LTEP05730288.7T priority patent/LT1729739T/lt
Priority to HRP20161602TT priority patent/HRP20161602T1/hr
Priority to EA200601608A priority patent/EA011712B1/ru
Priority to DK05730288.7T priority patent/DK1729739T3/en
Priority to HUE05730288A priority patent/HUE031058T2/en
Priority to JP2007505484A priority patent/JP4948392B2/ja
Priority to US10/599,154 priority patent/US20070172524A1/en
Priority to PT57302887T priority patent/PT1729739T/pt
Priority to PL05730288T priority patent/PL1729739T3/pl
Priority to PCT/EP2005/003277 priority patent/WO2005094793A1/en
Priority to EP05730288.7A priority patent/EP1729739B1/de
Priority to UAA200611343A priority patent/UA86969C2/uk
Priority to ES05730288.7T priority patent/ES2603856T3/es
Publication of DE102004019845A1 publication Critical patent/DE102004019845A1/de
Priority to NO20064934A priority patent/NO20064934L/no
Priority to US12/477,727 priority patent/US20100172995A1/en
Priority to CY20161101118T priority patent/CY1118180T1/el
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Diese Erfindung betrifft ein Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung von Perindopril oder einem Salz davon, das einen Feuchtgranulierungsschritt vermeidet und zu sehr stabilen pharmazeutischen Zusammensetzungen, wie Tabletten, führt.
DE200410019845 2004-03-29 2004-03-29 Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung Withdrawn DE102004019845A1 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DE200410019845 DE102004019845A1 (de) 2004-03-29 2004-03-29 Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
PL05730288T PL1729739T3 (pl) 2004-03-29 2005-03-29 Sposób wytwarzania stałej kompozycji farmaceutycznej
PCT/EP2005/003277 WO2005094793A1 (en) 2004-03-29 2005-03-29 Process for preparing a solid pharmaceutical composition
EA200601608A EA011712B1 (ru) 2004-03-29 2005-03-29 Способ производства твёрдой фармацевтической композиции
DK05730288.7T DK1729739T3 (en) 2004-03-29 2005-03-29 PROCESS FOR THE PREPARATION OF A solid pharmaceutical composition.
HUE05730288A HUE031058T2 (en) 2004-03-29 2005-03-29 A method of producing a solid pharmaceutical composition
JP2007505484A JP4948392B2 (ja) 2004-03-29 2005-03-29 固形薬学的組成物を調製するためのプロセス
US10/599,154 US20070172524A1 (en) 2004-03-29 2005-03-29 Process for preparing a solid pharmaceutical composition
PT57302887T PT1729739T (pt) 2004-03-29 2005-03-29 Processo para a preparação de uma composição farmacêutica sólida
LTEP05730288.7T LT1729739T (lt) 2004-03-29 2005-03-29 Kietos farmacinės kompozicijos gamybos būdas
HRP20161602TT HRP20161602T1 (hr) 2004-03-29 2005-03-29 Postupak priprave čvrstog farmaceutskog pripravka
EP05730288.7A EP1729739B1 (de) 2004-03-29 2005-03-29 Verfahren zur herstellung einer festen pharmazeutischen zusammensetzung
UAA200611343A UA86969C2 (uk) 2004-03-29 2005-03-29 Спосіб виробництва твердої фармацевтичної композиції периндоприлу
ES05730288.7T ES2603856T3 (es) 2004-03-29 2005-03-29 Procedimiento para preparar una composición farmacéutica sólida
NO20064934A NO20064934L (no) 2004-03-29 2006-10-27 Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
US12/477,727 US20100172995A1 (en) 2004-03-29 2009-06-03 Process For Preparing A Solid Pharmaceutical Composition
CY20161101118T CY1118180T1 (el) 2004-03-29 2016-11-03 Μεθοδος για παρασκευη στερεας φαρμακευτικης συνθεσης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE200410019845 DE102004019845A1 (de) 2004-03-29 2004-03-29 Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung

Publications (1)

Publication Number Publication Date
DE102004019845A1 true DE102004019845A1 (de) 2005-10-20

Family

ID=35456073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200410019845 Withdrawn DE102004019845A1 (de) 2004-03-29 2004-03-29 Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung

Country Status (2)

Country Link
DE (1) DE102004019845A1 (de)
UA (1) UA86969C2 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
WO2001097809A2 (en) * 2000-06-16 2001-12-27 Wyeth Method of treating cardiovascular disease using rapamycin
FR2834893A1 (fr) * 2002-01-23 2003-07-25 Servier Lab Composition pharmaceutique orodispersible de perindopril
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
WO2001097809A2 (en) * 2000-06-16 2001-12-27 Wyeth Method of treating cardiovascular disease using rapamycin
FR2834893A1 (fr) * 2002-01-23 2003-07-25 Servier Lab Composition pharmaceutique orodispersible de perindopril
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Serva-Spezifikation unter www.serva.de/products/ pdf/14204.pdf(gutachtlich Stellungsnahme) *

Also Published As

Publication number Publication date
UA86969C2 (uk) 2009-06-10

Similar Documents

Publication Publication Date Title
IL163659A0 (en) Acc inhibitors
BR0312464A (pt) Inibidores de tirosina quinases
SG165315A1 (en) Alpha2c adrenoreceptor agonists
YU59600A (sh) Supstituisane indolalkanoidske kiseline
TW200621722A (en) 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
TW200744588A (en) Pharmaceutical composition for external use
CL2007001915A1 (es) Compuesto cristalino de 6-[4-cloro-3-(4-etoxibencil)fenil]tetrahidropiran-2,3,4,5,-tetraol; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y su uso para preparar un medicamento para tratar diabetes, dislipidemia, obesidad, entre otras.
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
WO2007120689A3 (en) Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
TW200745004A (en) Novel compounds, their preparation and use
GEP20094638B (en) Benzimidazolone carboxylic acid derivatives
DE69922703D1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
WO2004050620A3 (en) Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
NO20083836L (no) N-hydroksyakrylamidforbindelser
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
AP2001002377A0 (en) Substituted phenoxyacetic acids.
BRPI0407519A (pt) derivados de benzofurano
WO2007133184A3 (en) Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
NO20073652L (no) Enantiomerer av 3-heteroaryl-8H-8-azabisyklo(3.2.1)okt-2-en og deres anvendelse som monoaminnevrotransmitter-gjenopptaksinhibitorer
BRPI0508392A (pt) materiais e métodos para tratar distúrbios de coagulação
EP2030512A4 (de) Geschmacksverbesserer

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20131001